tiprankstipranks
Trending News
More News >
Skyward Specialty Insurance Group, Inc. (SKWD)
NASDAQ:SKWD
US Market

Skyward Specialty Insurance Group, Inc. (SKWD) AI Stock Analysis

Compare
170 Followers

Top Page

SKWD

Skyward Specialty Insurance Group, Inc.

(NASDAQ:SKWD)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
$55.00
▲(14.06% Upside)
Action:ReiteratedDate:03/03/26
Overall score reflects strong financial performance (scaling revenue, improved margins/ROE, robust cash generation and low historical leverage) and a supportive valuation (P/E ~11.95). Offsetting factors are mixed technical momentum (below the 200-day and slightly negative MACD) and earnings-call risks centered on higher post-acquisition leverage and select underwriting/investment headwinds despite reiterated guidance and strong underwriting metrics.
Positive Factors
Revenue & Scale
Skyward has scaled revenues materially to $1.41B (2025), reflecting durable top-line expansion across specialty niches. Sustained premium growth supports underwriting leverage, broadens distribution economics, and improves ability to absorb fixed costs while funding targeted product expansion over months to years.
Underwriting Discipline
An 88.5% combined ratio and record underwriting income indicate persistent pricing adequacy and claims control in specialty lines. Durable underwriting discipline in technical niches helps sustain margins through underwriting cycles and supports predictable earnings beyond short-run rate moves.
Conservative Reserves & Diversification
High IBNR share (74%) and a book weighted to short-tail lines reduce reserve duration and interest-rate sensitivity. Coupled with a diversified portfolio where no division exceeds ~16% and focused specialty products, this enhances capital resilience and lowers the risk of protracted reserve shocks over the medium term.
Negative Factors
Rise in Financial Leverage
Debt-to-capital jumping to ~28%–29% materially increases financial leverage and interest obligations versus recent low-leverage levels. Higher leverage can constrain capital deployment, raise refinancing and rating risk, and reduce flexibility to absorb underwriting stress while integration proceeds over the next several quarters.
Reserve Volatility in Auto
Approximately $25M of adverse development in commercial/excess auto highlights reserve and frequency/severity volatility in auto lines. Auto exposures are historically cyclical; persistent adverse development could erode underwriting margins and require higher pricing or reserve strengthening in coming reporting periods.
Investment/Alternative-Asset Risk
Negative marks on private credit and alternative holdings, though a modest share (~3.8%), show investment-return volatility. As investment income is a core earnings driver for P&C insurers, continued alternative underperformance or mark-to-market swings could compress net income and capital buffers over time.

Skyward Specialty Insurance Group, Inc. (SKWD) vs. SPDR S&P 500 ETF (SPY)

Skyward Specialty Insurance Group, Inc. Business Overview & Revenue Model

Company DescriptionSkyward Specialty Insurance Group, Inc., an insurance holding company, engages in underwriting commercial property and casualty insurance coverages in the United States. The company offers general liability, excess liability, professional liability, commercial auto, group accident and health, property, surety, and workers' compensation insurance products. Skyward Specialty Insurance Group, Inc. was incorporated in 2006 and is headquartered in Houston, Texas.
How the Company Makes MoneySkyward Specialty Insurance Group generates revenue primarily through the underwriting of insurance policies. The company collects premiums from policyholders in exchange for coverage against specific risks. Key revenue streams include premiums from property and casualty insurance, specialty insurance products, and risk management services. Additionally, SKWD may earn investment income from its reserves and surplus funds, which are allocated in various investment instruments. Strategic partnerships with brokers and agents also enhance their distribution channels, facilitating wider reach and penetration into niche markets, contributing to overall revenue growth.

Skyward Specialty Insurance Group, Inc. Earnings Call Summary

Earnings Call Date:Feb 23, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 30, 2026
Earnings Call Sentiment Positive
The call conveyed strong operational and financial performance with multiple record metrics (notably adjusted operating income, underwriting income, robust premium growth, improving combined ratio, conservative reserving, and accretive strategic M&A). Challenges were largely manageable: some alternative asset underperformance, pockets of adverse development in commercial auto, heightened near-term leverage from the Apollo transaction, and competitive pressure in property and certain specialty lines. Overall, the positive financial results, disciplined reserving, portfolio diversification and strategic upside from Apollo and the Uber AV partnership materially outweigh the identified challenges.
Q4-2025 Updates
Positive Updates
Record Operating and Underwriting Income
Fourth quarter adjusted operating income increased 47% to $49.0M ($1.17 per diluted share) and underwriting income reached an all-time high of $41M; fourth consecutive quarter of record results for these metrics.
Strong Premium Growth
Gross written premiums grew 13% in the quarter and 24% for the full year; net written premiums grew 25% for the year, driven by A&H, Surety and Specialty Programs.
Outstanding Returns and Book Value Expansion
Reported ROE of 18.9% and return on tangible equity of 20.9% for the year; fully diluted book value per share rose to $23.87 (up 5% vs Q3 and up 26% year-over-year), with post-Apollo BVPS expected to be $26.00–$26.10.
Improved Underwriting Metrics
Fourth quarter combined ratio improved 7.3 points year-over-year to 88.5%; loss ratio was 59.6%, including $7.5M (2.1 points) of favorable prior-year development across primarily surety and property.
Conservative & Strengthened Reserve Position
Ended the year with 74% of reserves in IBNR (highest level in company history) and a pay-to-incurred of 65% (consistent with 2024), reflecting conservative reserving and shortened liability duration.
Investment Portfolio Momentum
Net investment income increased by $3M in Q4 vs prior-year quarter; deployed $52M at a 5.6% yield in Q4 with an embedded yield of 5.3% (up from 5.1% a year ago); $44M of alternative capital returned and reinvested into fixed income.
Balanced Portfolio & Targeted Growth Areas
More than 20% growth in Surety, A&H and Specialty Programs; portfolio diversification with 58% in short-tail lines and 48% in lines less exposed to P&C cycles; largest division is only 16% of premium.
Strategic M&A and Market Partnerships
Completed acquisition of Apollo (expected accretive), with Apollo growth ~20% and combined ratio ~89% in 2025; Apollo named sole carrier partner to Uber for an embedded autonomous vehicle insurance product (AVIP), reinforcing differentiated capabilities and growth runway.
Capital & Capital Deployment Flexibility
Finished Q4 with modest financial leverage (under 11% debt-to-capital) and reiterated intent to opportunistically repurchase shares; operational capital base supports 2026 plan.
Negative Updates
Rising Near-Term Financial Leverage from Apollo Transaction
While debt-to-capital was under 11% at year-end, leverage is expected to increase to approximately 28%–29% in Q1 2026 due to debt related to the Apollo transaction, representing near-term balance sheet leverage risk.
Alternative Asset Performance Disappointing
Alternative asset portfolio produced negative marks (underlying -$2M on private credit holdings) and had disappointing 2025 results; although representing only 3.8% of the portfolio at year-end (down from 6%), this segment underperformed.
Adverse Development in Commercial Auto
Some adverse reserve development in recent accident years (commercial auto and excess auto), noted at roughly ~$25M across accident years 2022 and 2024, partially offset by favorable development elsewhere.
Competitive Pressure in Property & Certain Lines
Market became more competitive at year-end, particularly in property, E&S and Professional Lines; this led to writing less new business in some divisions and continued pressure on property pricing versus the prior year.
Expense & Acquisition Cost Dynamics
Quarterly expense ratio was 28.9% (in line with guidance) but higher acquisition costs driven by business mix shifts and fourth-quarter profit-share true-ups added pressure on controllable expense improvements.
Specialty Programs Growth to Moderate
Management expects flatter growth in Specialty Programs going forward as the benefit from two programs added in early 2025 is fully reflected in written premium, reducing near-term incremental growth from that source.
Company Guidance
Management confirmed that the December 3 guidance for 2026 is unchanged and reiterated several near‑term targets: an expense ratio in the sub‑30s (Q4 was 28.9%), retention consistent with guidance (64.9% year‑end) with mid‑70s retention on renewals, mid‑single‑digit pure rate gains ex‑global property, and submission growth solidly in the teens. On capital and balance‑sheet metrics they said Q4 fully diluted book value was $23.87 and, after the January 1 Apollo close, FD BV is expected to be $26.00–$26.10 (Apollo consideration included ~3.7M shares at $50), debt‑to‑capital will rise from under 11% at year‑end to roughly 28%–29% in Q1 2026, and the company will opportunistically repurchase shares. For context around the guidance they noted FY‑2025 operating performance (Q4 adjusted operating income $49M / $1.17 per diluted share; FY GWP growth 24%, Q4 GWP +13%; net written premiums +25% Y/Y), a combined ratio of 88.5% (loss ratio 59.6% including $7.5M of favorable prior‑year development), pay‑to‑incurred ~65%, and 74% of reserves in IBNR.

Skyward Specialty Insurance Group, Inc. Financial Statement Overview

Summary
Strong multi-year revenue scaling to $1.41B (2025) with solid profitability (2025 net margin ~12%, EBIT margin ~15.9%), strong ROE (~16.8%), and low reported leverage (debt-to-equity ~0.10 in 2025). Cash generation is robust (2025 FCF $403M, ~0.99x net income), but revenue growth decelerated in 2025 and parts of cash-flow coverage data are incomplete, while the sharp 2025 margin uplift could be less durable.
Income Statement
86
Very Positive
Revenue has scaled strongly from $448M (2020) to $1.41B (2025), with continued growth in 2025 (+5.7%). Profitability has improved materially versus the 2020 loss year, with 2025 net margin at ~12.0% and EBIT margin at ~15.9%. Margins have also trended up over time (notably gross margin expanding sharply in 2025), supporting higher earnings power. The main watch-out is growth deceleration in 2025 versus the very high expansion years earlier in the period, and the sharp gross margin step-up in 2025 could prove volatile if underwriting conditions normalize.
Balance Sheet
84
Very Positive
Leverage appears conservative for the period, with debt-to-equity improving to ~0.10 in 2025 (down from ~0.42 in 2020) and total debt relatively modest versus a $1.01B equity base. Equity has expanded substantially over time, and return on equity is strong at ~16.8% in 2025 (up from ~14.0% in 2024), indicating improving profitability on shareholder capital. The key risk is that, for an insurer, balance-sheet strength can be sensitive to underwriting/reserve outcomes and asset values; while not directly shown here, the rapid asset growth alongside margin expansion warrants monitoring for sustainability.
Cash Flow
78
Positive
Cash generation is strong: operating cash flow rose to $408M in 2025 and free cash flow to $403M, with free cash flow growth of +8.4% in 2025. Free cash flow closely tracks net income (about ~0.99x in 2025), which supports earnings quality. However, free cash flow dipped slightly in 2024 (negative growth), and the operating cash flow coverage ratio is reported as 0.0 in multiple years (likely missing/unsupported), limiting confidence in coverage comparisons across the full history.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.41B1.15B895.40M636.40M535.82M
Gross Profit622.11M327.89M271.65M168.20M134.35M
EBITDA227.88M165.59M124.02M60.29M58.53M
Net Income170.03M118.83M85.98M39.40M38.32M
Balance Sheet
Total Assets4.79B3.73B2.95B2.36B2.12B
Cash, Cash Equivalents and Short-Term Investments2.02B1.18B1.35B774.17M664.74M
Total Debt100.41M119.54M128.69M128.61M128.53M
Total Liabilities3.78B2.94B2.29B1.94B1.69B
Stockholders Equity1.01B794.00M661.03M421.66M426.08M
Cash Flow
Free Cash Flow402.62M300.89M335.03M206.61M173.13M
Operating Cash Flow408.08M305.12M338.19M208.94M175.28M
Investing Cash Flow-585.47M-243.69M-493.81M-193.38M-183.01M
Financing Cash Flow411.00K-4.23M130.95M2.18M1.38M

Skyward Specialty Insurance Group, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price48.22
Price Trends
50DMA
46.90
Positive
100DMA
47.22
Positive
200DMA
50.17
Negative
Market Momentum
MACD
0.33
Negative
RSI
58.31
Neutral
STOCH
81.85
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SKWD, the sentiment is Positive. The current price of 48.22 is above the 20-day moving average (MA) of 45.62, above the 50-day MA of 46.90, and below the 200-day MA of 50.17, indicating a neutral trend. The MACD of 0.33 indicates Negative momentum. The RSI at 58.31 is Neutral, neither overbought nor oversold. The STOCH value of 81.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SKWD.

Skyward Specialty Insurance Group, Inc. Risk Analysis

Skyward Specialty Insurance Group, Inc. disclosed 40 risk factors in its most recent earnings report. Skyward Specialty Insurance Group, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Skyward Specialty Insurance Group, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$2.27B7.3140.02%0.82%8.71%17.26%
77
Outperform
$2.14B12.1618.85%22.51%2.19%
76
Outperform
$1.11B11.559.97%4.59%13.35%16.56%
73
Outperform
$2.41B5.4352.29%
69
Neutral
$2.13B17.667.08%2.88%16.22%69.80%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
58
Neutral
$756.90M52.8111.32%38.50%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SKWD
Skyward Specialty Insurance Group, Inc.
48.65
-3.44
-6.60%
SAFT
Safety Insurance Group
76.32
4.28
5.95%
STC
Stewart Information Services
70.01
1.32
1.92%
HCI
HCI Group
174.35
38.45
28.30%
ROOT
Root
48.68
-94.07
-65.90%
SLDE
Slide Insurance Holdings, Inc.
19.41
-3.89
-16.70%

Skyward Specialty Insurance Group, Inc. Corporate Events

Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
Skyward Specialty Completes Apollo Acquisition and Equity Issuance
Positive
Jan 6, 2026

On December 30, 2025, Skyward Specialty entered into a new unsecured senior delayed draw term loan facility totaling $300 million, split between Tranche A maturing January 1, 2028 and Tranche B maturing July 2, 2029, with pricing tied to term SOFR or a base rate plus a margin, and customary covenants on leverage, capital, ratings and liquidity, as well as a related guaranty from most non-insurance subsidiaries and an amendment to its existing credit agreement to permit pre-funding of revolving loans. Using proceeds from this new facility and its existing credit agreement, the company completed the previously announced acquisition of U.K.-based Apollo Group Holdings Limited on the January 2, 2026 closing date, paying roughly $555 million through $371 million in cash and the issuance of 3.68 million common shares, a move that expands Skyward Specialty’s presence at Lloyd’s of London and broadens its product and geographic reach in specialty insurance markets.

The most recent analyst rating on (SKWD) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Skyward Specialty Insurance Group, Inc. stock, see the SKWD Stock Forecast page.

Financial DisclosuresM&A Transactions
Skyward Specialty Gets Approval for Apollo Acquisition
Positive
Dec 3, 2025

On December 3, 2025, Skyward Specialty Insurance Group, Inc. announced it has received regulatory and minority shareholder approvals for its acquisition of Apollo Group Holdings Limited, with the transaction expected to close in early 2026. The company also provided its 2026 financial guidance, projecting significant growth in gross written premiums, net income, and adjusted operating income, reflecting the anticipated impact of the Apollo acquisition and its commitment to delivering top quartile results.

The most recent analyst rating on (SKWD) stock is a Buy with a $64.00 price target. To see the full list of analyst forecasts on Skyward Specialty Insurance Group, Inc. stock, see the SKWD Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 03, 2026